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ADVANCES IN BIOMEDICAL ENGINEERING. Vol. 5. Edited by J.H.U. Brown and James
F. Dickson, III. New York, Academic Press, 1975. 324 pp. $34.00.
The editors of this book define biomedical engineering "as the application of
principles and practices of engineering to basic and applied biomedical research,
development, and the delivery of health care." The fifth volume ofthis series presents
the same diversity of subjects that has characterized the preceding volumes and
conveys a balanced view of the latest developments in the rapidly growing field of
biomedical engineering.
The first chapterthatdealswithcontrolled deliveryofdrugsgives abriefsummary of
the methods, problems and opportunities associated with noveltherapeuticsystems. It
is hoped that a more detailed account of the subject will be given in a later volume
because this short chapter (34 pages)just whetstheappetite ofthe readertolearnmore
about new modes ofdrug administration. "Biomaterials-The Interfacial Problem" is
the title of the longest chapter (by Hench and Ethridge) in the book. The authors'
approach is focused on the physical properties of interfaces, and some may find it
unsatisfactory that biochemical phenomena receive less attention. In view of the
present status of this field, it is not surprising that this review chapter raises more
questions than it can answer. Physiological measurement systems for advanced space
missions is the subject of S.L. Pool's chapter, which gives an account of many
bioinstrumentation systems developed by NASA for use in space flights. The survey
deals with a wide variety of measurements and provides much information not
available in the general literature.
The last chapter by Attinger and Theodoridis is concerned with the analysis of
societal systems. The authors discuss the fundamentals ofthe systems approach in an
essentially non-mathematical fashion and cover a very wide area in applying them to
man and society with particular regardto problems related to health. Theirendeavoris
directed toward the reader, who wants to be acquainted with this branch of bioen-
gineering. By and large the book is a valuable addition to this excellent series.
CSABA HORVATH
Department ofEngineering and Applied Science
Yale University
ANTIVIRAL DRUGS, MODE OF ACTION AND CHEMOTHERAPY OF VIRAL INFECTIONS OF
MAN. By Yechiel Becker. New York, S. Karger, 1976. 130 pp. $30.50.
Although the availability of clinically useful antiviral drugs is rather meager today,
the number of substances being evaluated for potential antiviral activity this past
decade has increased markedly. Unfortunately most synthetic or naturally occurring
substances for a variety of reasons have no clinical utility. A better understanding of
the molecular basis for the failure or success of these compounds may provide
appropriate information for the development of useful antiviral agents. Dr. Becker's
review of the more important antiviral substances with an emphasis on their mechan-
ism ofaction will be ofvalue for such an objective. The agents have beengrouped into
chapters based on our current understanding ofthe molecular event in the replication
of the virus that is affected.
In spite of the excellence in presentation there are, however, a few points of
confusion and concernthatthereaderwhoisnewtothefield ofantiviralchemotherapy
should be made aware of. For example, amantadine is stated to prevent viral penetra-
tion in Table III, yet to inhibit virus uncoating on page twenty. It is unfortunate that224 BOOK REVIEWS
discussion of the mode of action of ara-C does not include reference to its incorpora-
tion into RNA, a finding that may be of critical importance. Although IUdR and
BUdR are indeed incorporated into cellular DNA, not only is it not true that FUdRis
similarly incorporated, but also the references cited for this are incorrect (p. 86).
Although Dr. Becker interprets Table X (p. 95)toshowthataplacebointhetreatment
of herpes keratitis produces effects similar to those obtained with IUdR, the data
clearly show IUdR to have a 72% success rate relative to a 24% success rate with
placebo.
An extensive Table ofContents (five pages) is given. However, adetailedalphabeti-
cal index would have been of great value, particularly when referring to those com-
pounds that have multiple sites of inhibition. For example, the effect of rifamycin
derivatives on RNA-dependent DNA polymerase is discussed on p. 29, but only on
p. 83 do we learn that its inhibition of vaccinia virus may be related to an effect on
processing of a precursor protein. The rapidity in development of antiviral agents
today is exemplified bythefailuretoincludediscussion ofphosphonoaceticacidwhich
has been undergoing extensive study as an antiviral drug the past few years.
The above caveatsshould notdistractfromthepotential usefulnessofthisbook. Itis
to be hoped that a future revision will not only rectify these loose ends, butalsowillbe
produced at a lower cost. Dr. Beckeristo becommendedforhisexcellent presentation
and clear discussion of antiviral agents based on their mode ofaction. This will not
only be ofgreat value to those seekingnewdirections ineffectivedrugs, butwillalsobe
of value to graduate students, medical students and physicians in helping them
understand how antiviral drugs exert their biological effects.
WILLIAM H. PRUSOFF
Department ofPharmacology
Yale University School ofMedicine
IMMUNE DEPRESSION AND CANCER. Edited by G.W. Siskind, C.L. Christian, and S.D.
Litwin. New York, Grune and Stratton, 1975. 209 pp. $12.50.
This book is based on the proceedings ofthe "Second Irwin Strasburger Memorial
Seminar on Immunology," a symposium designed to bring together "outstanding
medical scientists to discuss current aspects of problems related to both immunology
and cancer." Readers influenced by the book's title and consequently hopeful of
learning something ofthe role ofimmune depression in cancer are in for adisappoint-
ment. Instead theywill findeight presentations, a ratherunevenmixtureofreviewsand
research reports, which deal mostly with mechanisms of immune control.
The first article, by R.K. Gershon, gives an outline ofthe activities ofsuppressor T
cells. The next two contributions deal with the role of these cells in immunodeficient
patients (T.A. Waldmann et al.), and in the pathogenesis of autoimmunity in New
Zealand mice (A.D. Steinberg et al.). D.H. Katz reviews current concepts ofimmuno-
logical tolerance including active suppression ofimmune responsiveness by T cells. A
series ofexperiments designed to study the mechanism ofantibody mediated immune
suppression is described by G.W. Siskind. One form ofthis kind ofsuppression is re-
examined by W.Q. Ascari and W. Pollack. S.R. Cooperband etal. report onanumber
of natural immunosuppressive factors found in serum, and in a variety ofnormal and
cancerous tissues. Lastly, A.C. Aisenberg reviews B- and T-cell function in malignant
lymphoma.